Published in
Springer Nature [academic journals on nature.com], British Journal of Cancer, 5(110), p. 1148-1154, 2014
DOI: 10.1038/bjc.2013.813
Links
- Springer Nature [academic journals on nature.com] | PDF
- ORCID
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
Tools
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: A multicentre Phase I/II trial
Journal article published in 2014 by
E. Samalin,
O. Bouché,
S. Thézenas,
E. Francois,
A. Adenis,
J. Bennouna 
,
J. Taieb,
F. Desseigne,
J. F. Seitz,
T. Conroy,
M. P. Galais,
E. Assenat,
E. Crapez,
S. Poujol,
F. Bibeau
and other authors.
,
J. Taieb,
F. Desseigne,
J. F. Seitz,
T. Conroy,
M. P. Galais,
E. Assenat,
E. Crapez,
S. Poujol,
F. Bibeau
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 